Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently confirmed by adequate lung biopsy. Retrospective analysis of 104 patients with IPF who had open lung biopsy (OLB...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 1998, Vol.157 (1), p.199-203
Hauptverfasser: BJORAKER, J. A, RYU, J. H, EDWIN, M. K, MYERS, J. L, TAZELAAR, H. D, SCHROEDER, D. R, OFFORD, K. P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 203
container_issue 1
container_start_page 199
container_title American journal of respiratory and critical care medicine
container_volume 157
creator BJORAKER, J. A
RYU, J. H
EDWIN, M. K
MYERS, J. L
TAZELAAR, H. D
SCHROEDER, D. R
OFFORD, K. P
description Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently confirmed by adequate lung biopsy. Retrospective analysis of 104 patients with IPF who had open lung biopsy (OLB) at Mayo Medical Center from 1976 to 1985 was performed to establish the overall survival rate, the spectrum of histopathological subgroups and their associated prognostic significance. The study group consisted of 54 men and 50 women with a median age of 63 yr. Median survival was 3.8 yr after diagnosis by OLB with an estimated 10 yr survival of 27%. Current histopathologic review showed a heterogeneous group including usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), nonspecific interstitial pneumonia/fibrosis (NSIP), acute interstitial pneumonia (AIP), bronchiolitis, bronchiolitis obliterans organizing pneumonia (BOOP), and others. Median survival of the UIP group was 2.8 yr which is significantly worse (p < 0.001) than for other subgroups of chronic interstitial pneumonias. IPF includes several histopathologic subgroups with significantly different survival rates. Patients with UIP have worse survival than patients with other types of idiopathic chronic interstitial pneumonias including NSIP. Accurate histopathologic classification is essential for prognostication in patients with IPF.
doi_str_mv 10.1164/ajrccm.157.1.9704130
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79671248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79671248</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-ad69f017c35bf739f32c7ce18ab74968d13d1a58deb81bd4717215d3f5b570113</originalsourceid><addsrcrecordid>eNo9kF1LwzAUhoMoc07_gUIvxLvOnCZp2ksZfsFAQQXvQpomW0bb1KS98N-bubKr8_G-5-XwIHQNeAmQ03u580q1S2B8CcuSYwoEn6A5MMJSGufT2GNOUkrL73N0EcIOY8gKwDM0KyllBOM5-nj3btO5MFiVBLvprLFKdkonziRbGwbXy2HrGrfZ62MV9BAS2yW2tv9K3PZj07pO-t_E2Mq7YMMlOjOyCfpqqgv09fT4uXpJ12_Pr6uHdapIyYdU1nlpMHBFWGU4KQ3JFFcaCllxWuZFDaQGyYpaVwVUNeXAM2A1MaxiHAOQBbo75Pbe_Yw6DKK1QemmkZ12YxC8zDlktIhGejCq-F_w2oje2za-LACLPUtxYCkiSwFiYhnPbqb8sWp1fTya4EX9dtJlULIxPoKz4WjLYnJBKPkDL2t_kg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79671248</pqid></control><display><type>article</type><title>Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>American Thoracic Society (ATS) Journals Online</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>BJORAKER, J. A ; RYU, J. H ; EDWIN, M. K ; MYERS, J. L ; TAZELAAR, H. D ; SCHROEDER, D. R ; OFFORD, K. P</creator><creatorcontrib>BJORAKER, J. A ; RYU, J. H ; EDWIN, M. K ; MYERS, J. L ; TAZELAAR, H. D ; SCHROEDER, D. R ; OFFORD, K. P</creatorcontrib><description>Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently confirmed by adequate lung biopsy. Retrospective analysis of 104 patients with IPF who had open lung biopsy (OLB) at Mayo Medical Center from 1976 to 1985 was performed to establish the overall survival rate, the spectrum of histopathological subgroups and their associated prognostic significance. The study group consisted of 54 men and 50 women with a median age of 63 yr. Median survival was 3.8 yr after diagnosis by OLB with an estimated 10 yr survival of 27%. Current histopathologic review showed a heterogeneous group including usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), nonspecific interstitial pneumonia/fibrosis (NSIP), acute interstitial pneumonia (AIP), bronchiolitis, bronchiolitis obliterans organizing pneumonia (BOOP), and others. Median survival of the UIP group was 2.8 yr which is significantly worse (p &lt; 0.001) than for other subgroups of chronic interstitial pneumonias. IPF includes several histopathologic subgroups with significantly different survival rates. Patients with UIP have worse survival than patients with other types of idiopathic chronic interstitial pneumonias including NSIP. Accurate histopathologic classification is essential for prognostication in patients with IPF.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/ajrccm.157.1.9704130</identifier><identifier>PMID: 9445300</identifier><language>eng</language><publisher>New York, NY: American Lung Association</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anti-Inflammatory Agents - therapeutic use ; Biological and medical sciences ; Biopsy ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Pneumology ; Predictive Value of Tests ; Prednisone - therapeutic use ; Prognosis ; Proportional Hazards Models ; Pulmonary Fibrosis - classification ; Pulmonary Fibrosis - drug therapy ; Pulmonary Fibrosis - mortality ; Pulmonary Fibrosis - pathology ; Respiratory system : syndromes and miscellaneous diseases ; Retrospective Studies ; Survival Analysis</subject><ispartof>American journal of respiratory and critical care medicine, 1998, Vol.157 (1), p.199-203</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-ad69f017c35bf739f32c7ce18ab74968d13d1a58deb81bd4717215d3f5b570113</citedby><cites>FETCH-LOGICAL-c397t-ad69f017c35bf739f32c7ce18ab74968d13d1a58deb81bd4717215d3f5b570113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,4025,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2116834$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9445300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BJORAKER, J. A</creatorcontrib><creatorcontrib>RYU, J. H</creatorcontrib><creatorcontrib>EDWIN, M. K</creatorcontrib><creatorcontrib>MYERS, J. L</creatorcontrib><creatorcontrib>TAZELAAR, H. D</creatorcontrib><creatorcontrib>SCHROEDER, D. R</creatorcontrib><creatorcontrib>OFFORD, K. P</creatorcontrib><title>Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently confirmed by adequate lung biopsy. Retrospective analysis of 104 patients with IPF who had open lung biopsy (OLB) at Mayo Medical Center from 1976 to 1985 was performed to establish the overall survival rate, the spectrum of histopathological subgroups and their associated prognostic significance. The study group consisted of 54 men and 50 women with a median age of 63 yr. Median survival was 3.8 yr after diagnosis by OLB with an estimated 10 yr survival of 27%. Current histopathologic review showed a heterogeneous group including usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), nonspecific interstitial pneumonia/fibrosis (NSIP), acute interstitial pneumonia (AIP), bronchiolitis, bronchiolitis obliterans organizing pneumonia (BOOP), and others. Median survival of the UIP group was 2.8 yr which is significantly worse (p &lt; 0.001) than for other subgroups of chronic interstitial pneumonias. IPF includes several histopathologic subgroups with significantly different survival rates. Patients with UIP have worse survival than patients with other types of idiopathic chronic interstitial pneumonias including NSIP. Accurate histopathologic classification is essential for prognostication in patients with IPF.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pneumology</subject><subject>Predictive Value of Tests</subject><subject>Prednisone - therapeutic use</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Pulmonary Fibrosis - classification</subject><subject>Pulmonary Fibrosis - drug therapy</subject><subject>Pulmonary Fibrosis - mortality</subject><subject>Pulmonary Fibrosis - pathology</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kF1LwzAUhoMoc07_gUIvxLvOnCZp2ksZfsFAQQXvQpomW0bb1KS98N-bubKr8_G-5-XwIHQNeAmQ03u580q1S2B8CcuSYwoEn6A5MMJSGufT2GNOUkrL73N0EcIOY8gKwDM0KyllBOM5-nj3btO5MFiVBLvprLFKdkonziRbGwbXy2HrGrfZ62MV9BAS2yW2tv9K3PZj07pO-t_E2Mq7YMMlOjOyCfpqqgv09fT4uXpJ12_Pr6uHdapIyYdU1nlpMHBFWGU4KQ3JFFcaCllxWuZFDaQGyYpaVwVUNeXAM2A1MaxiHAOQBbo75Pbe_Yw6DKK1QemmkZ12YxC8zDlktIhGejCq-F_w2oje2za-LACLPUtxYCkiSwFiYhnPbqb8sWp1fTya4EX9dtJlULIxPoKz4WjLYnJBKPkDL2t_kg</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>BJORAKER, J. A</creator><creator>RYU, J. H</creator><creator>EDWIN, M. K</creator><creator>MYERS, J. L</creator><creator>TAZELAAR, H. D</creator><creator>SCHROEDER, D. R</creator><creator>OFFORD, K. P</creator><general>American Lung Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis</title><author>BJORAKER, J. A ; RYU, J. H ; EDWIN, M. K ; MYERS, J. L ; TAZELAAR, H. D ; SCHROEDER, D. R ; OFFORD, K. P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-ad69f017c35bf739f32c7ce18ab74968d13d1a58deb81bd4717215d3f5b570113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pneumology</topic><topic>Predictive Value of Tests</topic><topic>Prednisone - therapeutic use</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Pulmonary Fibrosis - classification</topic><topic>Pulmonary Fibrosis - drug therapy</topic><topic>Pulmonary Fibrosis - mortality</topic><topic>Pulmonary Fibrosis - pathology</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BJORAKER, J. A</creatorcontrib><creatorcontrib>RYU, J. H</creatorcontrib><creatorcontrib>EDWIN, M. K</creatorcontrib><creatorcontrib>MYERS, J. L</creatorcontrib><creatorcontrib>TAZELAAR, H. D</creatorcontrib><creatorcontrib>SCHROEDER, D. R</creatorcontrib><creatorcontrib>OFFORD, K. P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BJORAKER, J. A</au><au>RYU, J. H</au><au>EDWIN, M. K</au><au>MYERS, J. L</au><au>TAZELAAR, H. D</au><au>SCHROEDER, D. R</au><au>OFFORD, K. P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>1998</date><risdate>1998</risdate><volume>157</volume><issue>1</issue><spage>199</spage><epage>203</epage><pages>199-203</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently confirmed by adequate lung biopsy. Retrospective analysis of 104 patients with IPF who had open lung biopsy (OLB) at Mayo Medical Center from 1976 to 1985 was performed to establish the overall survival rate, the spectrum of histopathological subgroups and their associated prognostic significance. The study group consisted of 54 men and 50 women with a median age of 63 yr. Median survival was 3.8 yr after diagnosis by OLB with an estimated 10 yr survival of 27%. Current histopathologic review showed a heterogeneous group including usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), nonspecific interstitial pneumonia/fibrosis (NSIP), acute interstitial pneumonia (AIP), bronchiolitis, bronchiolitis obliterans organizing pneumonia (BOOP), and others. Median survival of the UIP group was 2.8 yr which is significantly worse (p &lt; 0.001) than for other subgroups of chronic interstitial pneumonias. IPF includes several histopathologic subgroups with significantly different survival rates. Patients with UIP have worse survival than patients with other types of idiopathic chronic interstitial pneumonias including NSIP. Accurate histopathologic classification is essential for prognostication in patients with IPF.</abstract><cop>New York, NY</cop><pub>American Lung Association</pub><pmid>9445300</pmid><doi>10.1164/ajrccm.157.1.9704130</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 1998, Vol.157 (1), p.199-203
issn 1073-449X
1535-4970
language eng
recordid cdi_proquest_miscellaneous_79671248
source MEDLINE; Journals@Ovid Complete; American Thoracic Society (ATS) Journals Online; EZB-FREE-00999 freely available EZB journals
subjects Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents - therapeutic use
Biological and medical sciences
Biopsy
Female
Humans
Male
Medical sciences
Middle Aged
Pneumology
Predictive Value of Tests
Prednisone - therapeutic use
Prognosis
Proportional Hazards Models
Pulmonary Fibrosis - classification
Pulmonary Fibrosis - drug therapy
Pulmonary Fibrosis - mortality
Pulmonary Fibrosis - pathology
Respiratory system : syndromes and miscellaneous diseases
Retrospective Studies
Survival Analysis
title Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T18%3A06%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20significance%20of%20histopathologic%20subsets%20in%20idiopathic%20pulmonary%20fibrosis&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=BJORAKER,%20J.%20A&rft.date=1998&rft.volume=157&rft.issue=1&rft.spage=199&rft.epage=203&rft.pages=199-203&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/ajrccm.157.1.9704130&rft_dat=%3Cproquest_cross%3E79671248%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79671248&rft_id=info:pmid/9445300&rfr_iscdi=true